Other Clinical Trial - Family Meeting Study for End Stage Renal Disease

Status Completed

Clinical Trial Summary

A randomized clinical trial for patients with end stage renal disease in which a family consultation condition is compared against a treatment as usual control condition on the hospital readmissions after 1 month as the primary outcome variable.

Clinical Trial Description

Patients hospitalized at Henry For Hospital who have end stage renal disease will complete baseline questionnaires and be randomized into the experimental or control condition. Patients randomized into the experimental condition will have a single family consultation session before the patient is discharged. A trained, master's level therapist will conduct the family consultation, which will use education, motivational interviewing, and other techniques to help the family engage and support the patient's health needs. Patients in both the experimental and control conditions will complete follow up questionnaires 1 month after discharge. Investigators will conduct chart reviews of outcome data, including readmissions, at 1, 3, and 6 months post-discharge. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02504021
Study type	Interventional
Source	Wayne State University
Contact
Status	Completed
Phase	N/A
Start date	July 2015
Completion date	October 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04087213` - Study of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD	N/A
Completed	`NCT02207088` - Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease	Phase 3
Not yet recruiting	`NCT03090828` - Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease	N/A
Completed	`NCT02237521` - The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease	N/A
Withdrawn	`NCT01691196` - Inflammation in Peritoneal Dialysis Patients: Effect of Obesity
Completed	`NCT01394341` - Liraglutide Treatment to Patients With Severe Renal Insufficiency	Phase 4
Active, not recruiting	`NCT00247507` - The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients	Phase 4
Completed	`NCT00307463` - Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation	Phase 4
Recruiting	`NCT00155363` - Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis	Phase 4
Completed	`NCT00234156` - The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers	N/A
Completed	`NCT00586131` - Arterial pH and Total Body Nitrogen Balances in APD	Phase 4
Active, not recruiting	`NCT05027074` - Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)	Phase 2
Recruiting	`NCT04575077` - The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation
Enrolling by invitation	`NCT05001009` - Goals of Care Conversations Study	N/A
Completed	`NCT01756508` - Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury	Phase 2
Recruiting	`NCT03862859` - The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis	Phase 4
Terminated	`NCT03661229` - Cardiovascular and Respiratory Assessment Using Biometric Signals in a Non-contact Monitoring Device	N/A
Completed	`NCT03288922` - Protein-bound Toxin Removal Between Limited Blood Flow Super High-flux Online HDF and High-Efficiency Online HDF	N/A
Completed	`NCT02572882` - Gut Microbiome and p-Inulin in Hemodialysis	N/A
Completed	`NCT02360748` - A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients	N/A